Bellevue Biotech CA CHF

Reference Data

ISIN CH0269987423
Valor Number 26998742
Bloomberg Global ID
Fund Name Bellevue Biotech CA CHF
Fund Provider Bellevue Asset Management AG Zürich, Switzerland
Phone: +41 44 267 67 00
E-Mail: info@bellevue.ch
Web: www.bellevue.ch
Fund Provider Bellevue Asset Management AG
Representative in Switzerland
Distributor(s) Zürcher Kantonalbank
Zürich
Phone: +41 44 293 93 93
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Switzerland
Issuing Condition Special conditions apply to the issue of units
Redemption Condition Special conditions apply to the redemption of units
Investment Strategy *** N/A
Peculiarities

Fund Prices

Current Price * 102.08 CHF 02.04.2025
Previous Price * 100.64 CHF 01.04.2025
52 Week High * 112.44 CHF 16.07.2024
52 Week Low * 95.86 CHF 19.04.2024
NAV * 102.08 CHF 02.04.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 27,470,296
Unit/Share Assets *** 5,769,297
Trading Information SIX

Performance

YTD Performance -1.44% 31.12.2024
02.04.2025
1 month -4.80% 03.03.2025
02.04.2025
3 months -3.29% 03.01.2025
02.04.2025
6 months -1.39% 02.10.2024
02.04.2025
1 year +0.07% 02.04.2024
02.04.2025
2 years +0.35% 03.04.2023
02.04.2025
3 years -7.84% 04.04.2022
02.04.2025
5 years +19.39% 02.04.2020
02.04.2025

Tax Data

Equity Participation Rate in % 80.29
Share of Total Fund Assets in %
Real Estate Rate in % 0.00
ADDI
ADDI Date

Top 10 Holdings ***

Gilead Sciences Inc 9.91%
Amgen Inc 8.58%
Vertex Pharmaceuticals Inc 7.55%
Regeneron Pharmaceuticals Inc 6.19%
AstraZeneca PLC ADR 4.26%
Alnylam Pharmaceuticals Inc 3.62%
argenx SE ADR 3.18%
Verona Pharma PLC ADR 3.16%
BeiGene Ltd ADR 2.73%
Illumina Inc 2.04%
Last data update 28.02.2025

Cost / Risk

TER 1.52%
TER date 30.09.2024
Performance Fee *** 10.00%
PTR
Max. Management Fee *** 1.80%
Ongoing Charges ***
SRRI ***
SRRI date *** 31.03.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)